04 · GLP-1 & Metabolic Weight Loss

How much does retatrutide cost?

Retatrutide has no legitimate retail price, because it is an investigational medicine the FDA has not approved. As of late 2026 it is still in Phase 3 trials: it cannot be legally prescribed, compounded or sold, and the FDA has said any product sold as retatrutide is unapproved and potentially unsafe. Eli Lilly has said it plans to file for approval around the first quarter of 2027. For weight loss you can access now, the GLP-1 options with published prices are compounded semaglutide and tirzepatide.

Affiliate disclosure: we may earn a commission if you sign up with Embody and Refills through links on this page, at no extra cost to you. Commissions never change our rankings or data. How we make money

Why retatrutide has no price yet

Retatrutide is an investigational triple-hormone (GLP-1/GIP/glucagon) medicine from Eli Lilly, still in Phase 3 clinical trials as of late 2026. The FDA has not approved it for any use.

Because it is unapproved, it cannot be legally prescribed, sold or dispensed outside a clinical trial, so there is no legitimate program price to compare. Any site advertising retatrutide for sale is operating outside that framework.

Is compounded retatrutide legal or safe?

No. The FDA has stated that retatrutide cannot be legally compounded, because it is not a component of any FDA-approved drug. The agency has warned that products sold as retatrutide are unapproved and that anything claiming to be it may be unsafe, counterfeit or mislabeled.

Gray-market retatrutide has been reaching patients ahead of any approved version, and regulators have sent warning letters to telehealth sellers over compounded GLP-1 claims. This page is informational and not medical advice; talk to a licensed clinician before considering any weight-loss medication.

When might retatrutide be available — and what it could cost

Eli Lilly has said it plans to submit retatrutide for approval around the first quarter of 2027. FDA review of a new application typically takes about 10 to 12 months, so the earliest a legitimate, priced product could reach patients would follow that process.

Until there is an approved product and a published launch price, no accurate cost can be given, and we do not estimate one. We will add verified pricing here if and when retatrutide is approved and sold through legitimate programs.

GLP-1 options you can actually get now

If you are comparing weight-loss options today, the GLP-1 medicines available through online programs with published prices are semaglutide and tirzepatide. See our tirzepatide cost guide and semaglutide cost guide, or run the numbers by program in the GLP-1 cost calculator.

Common questions

Is retatrutide FDA approved?

No. As of late 2026 retatrutide is investigational and in Phase 3 trials. It has not been approved by the FDA for any use.

Can I buy retatrutide now?

Not legally. Outside clinical trials (and a limited early-access program the manufacturer has described), retatrutide is not available, and any product sold as retatrutide is unapproved and potentially unsafe.

Is compounded retatrutide legal?

No. The FDA has said retatrutide cannot be compounded under federal law because it is not a component of an FDA-approved drug.

How much will retatrutide cost when approved?

Unknown. No legitimate price exists until it is approved and launched, so we do not estimate one.

What weight-loss options are available now?

GLP-1 medicines with published online prices today are semaglutide and tirzepatide, available through licensed telehealth programs.

Every number comes from the program profiles, which list their sources and check dates; values we couldn't confirm are left out, not estimated. Prices change often — confirm with the program before enrolling. We may earn a commission from some programs; that never changes the numbers. Not medical advice. See our methodology and editorial policy.

Data checked through · Telehealth near me